Telemedicine in Oncology
1School of Nursing, Columbia University, New York, NY.
Clinical Journal of Oncology Nursing
|January 23, 2016
Summary
Telemedicine offers remote healthcare access for patients facing travel challenges due to remote locations or lack of transportation. This growing field benefits patients, providers, and the overall healthcare system.
Area of Science:
- Healthcare Technology
- Public Health
Background:
- Access to healthcare can be limited for individuals in remote locations or those without transportation.
- Telemedicine presents a solution to overcome geographical and logistical barriers in healthcare delivery.
Purpose of the Study:
- To explore the benefits of telemedicine for patients, healthcare providers, and the healthcare system.
- To highlight the growing opportunities in remote healthcare access.
Main Methods:
- This study focuses on the conceptual benefits and potential of telemedicine.
- It reviews existing literature and case examples of remote healthcare delivery.
Main Results:
- Telemedicine expands healthcare accessibility for underserved populations.
- It offers flexibility and convenience for patients and can improve provider efficiency.
- Potential exists for significant positive impacts on the healthcare system's reach and effectiveness.
Conclusions:
- Telemedicine is a vital and expanding component of modern healthcare.
- It addresses critical access issues and offers a scalable model for future healthcare delivery.
Related Concept Videos
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies
3.0K
3.0K
Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Targeted Cancer Therapies
1.7K
1.7K


